Advances in ALS workshop summary: Research and future goals

Neurology

Volumn 47, Issue 4 SUPPL., 1996, Pages

  Brooke, Michael H ^a   Strong, Michael J ^b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; EXCITATORY AMINO ACID; GLUTAMIC ACID; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GROWTH FACTOR; NEUROFILAMENT PROTEIN; NEUROTROPHIC FACTOR; SOMATOMEDIN C;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL DEATH; GENE MUTATION; HUMAN; IMMUNE MEDIATED INJURY; MOTONEURON; NERVE CELL DEGENERATION; NEUROFILAMENT; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RESEARCH;

EID: 0029848143     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.47.4_suppl_2.108s     Document Type: Article

References (63)

1. Hayashi H, Kato S. Total manifestations of amyotrophic lateral sclerosis. J Neurol Sci 1989;93:19-35.
2. Hayashi H, Kato S, Kawada A. Amyotrophic lateral sclerosis patients living beyond respiratory failure. J Neurol Sci 1991; 105:73-78.
3. Kato S, Oda M, Tanabe H. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 1993;19:300-304.
4. Carpenter S. Proximal axonal enlargement in motor neuron disease. Neurology 1968;18:841-851.
5. Leigh PN, Dodson A, Swash M, Brion J-P, Anderton BH. Cytoskeletal abnormalities in motor neuron disease. Brain 1989;112:521-535.
6. Manetto V, Sternberger NH, Perry G, Sternberger LA, Gambetti P. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1988;47: 642-653.
7. Munoz DG, Greene C, Perl DP, Selkoe DJ. Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol 1988;47:9-18.
8. Murayama S, Bouldin TW, Suzuki K. Immunocytochemical and ultrastructural studies of upper motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol 1992;83:518-524.
9. Leigh P, Swash M. Cytoskeletal pathology in motor neuron disease. In: Rowland LP, ed. Advances in Neurology. Amyotrophic lateral sclerosis and other motor neuron diseases. New York: Raven Press, 1991;56:115-124.
10. Migheli A, Attanasio A, Schiffer D. Ubiquitin and neurofilament expression in anterior horn cells in amyotrophic lateral sclerosis: possible clues to the pathogenesis. Neuropathol Appl Neurobiol 1994;20:282-289.
11. Lee MK, Cleveland DW. Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. Curr Opin Cell Biol 1994;6:34-40.
12. Strong MJ, Garruto RM. Experimental paradigms of motor neuron degeneration. In: Woodruff ML, Nonneman A, eds. Animal models of toxin-induced neurological disorders. New York: Plenum Press, 1994:39-88.
13. Côte F, Collard J-F, Julien J-P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 1993;73:35-46.
14. Julien J-P, Côte F, Collard J-F. Mice overexpressing the human neurofilament heavy gene as a model of ALS. Neurobiol Aging 1995;16:487-492.
15. Xu Z, Cork LC, Griffin JW, Cleveland DW. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 1993;73:23-33.
16. Collard J-F, Côté F, Julien J-P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 1995;375:61-64.
17. Lee MK, Marszalek JR, Cleveland DW. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 1994;13:975-988.
18. 3 in New Zealand white rabbits. Acta Neuropathol 1995;90:57-67.
19. Gaytan-Garcia S, Kim H, Strong MJ. Spinal motor neuroaxonal spheroids in chronic aluminum neurotoxicity contain phosphatase-resistant high molecular weight neurofilament (NFH). Toxicology 1996;108:17-24.
20. Strong MJ, Gaytan-Garcia S. Proximal sciatic axotomy does not inhibit the induction of neurofilamentous inclusions following intracisternal aluminum chloride exposure. J Neuropathol Exp Neurol 1996;55:419-423.
21. Strong MJ, Jakowec DM. 200 kDa and 160 kDa neurofilament protein phosphatase resistance following in vivo aluminum chloride exposure. Neurotoxicology 1994;15:799-808.
22. Figlewicz DA, Krizus A, Martinoli MG, et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994;3: 1757-1761.
23. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
24. Deng H-X, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 1993;261:1047-1051.
25. Rothstein JD, Bristol LA, Hosler B, Brown RH Jr, Kuncl RW. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal motor neurons. Proc Natl Acad Sci USA 1994; 91:4155-4159.
26. Troy CM, Shelanski ML. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc Natl Acad Sci USA 1994;91:6384-6387.
27. Wong PC, Pardo CA, Borchelt DR, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995;14:1105-1116.
28. Bergeron C, Muntasser S, Somerville MJ, Weyer L, Percy ME. Copper/zinc superoxide dismutase mRNA levels are increased in sporadic amyotrophic lateral sclerosis. Brain Res 1994;659: 272-276.
29. Figlewicz DA, Garruto RM, Krizus A, Yanagihara R, Rouleau GA. The Cu/Zn superoxide dismutase gene in ALS and Parkinsonism-dementia of Guam. Neuroreport 1994;5:557-560.
30. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84.
31. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 1993;90:6591-6595.
32. Rothstein JD. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. In: Serratrice G, Munsat T, eds. Pathogenesis and therapy of amyotrophic lateral sclerosis. Philadelphia: Lippincott-Raven, 1995:7-20.
33. Hugon J, Vallat JM. Abnormal distribution of phosphorylated neurofilaments in the neuronal degeneration induced by kainic acid. Neurosci Lett 1990;119:45-48.
34. Englehardt JI, Appel SH, Killian JM. Experimental autoimmune motoneuron disease. Ann Neurol 1989;26:368-376.
35. Englehardt J, Appel SH. Motor neuron reactivity of sera from animals with autoimmune models of motor neuron destruction. J Neurol Sci 1990;96:333-352.
36. Englehardt JI, Siklos L, Kouves L, Smith RG, Appel SH. Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse 1995;20:185-199.
37. Smith RG, Hamilton S, Hofmann F, et al. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med 1992;327:1721-1728.
38. Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunological reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992;140:691-707.
39. Lampson LA, Kushner PD, Sobel RA. Strong expression of class II major histocompatibility complex (MHC) antigens in the absence of detectable T cell infiltration in amyotrophic lateral sclerosis (ALS) spinal cord. J Neuropathol Exp Neurol 1988;47:353.
40. Lampson LA, Kushner PD, Sobel RA. Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann Neurol 1990;28:365-372.
41. Troost D, van den Oord JJ, de Jong JMBV, Swaab DF. Lymphocyte infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol 1989;8:289-294.
42. Streit WJ, Graeber MB, Kreutzberg GW. Functional plasticity of microglia: a review. Glia 1988;1:301-307.
43. Thanos S. The relationship of microglial cells to dying neurons during natural neuronal cell death and axotomy-induced degeneration of the rat retina. Eur J Neurosci 1991;3:1189-1207.
44. Barron KD, Marciano FF, Amundson R, Mankes R. Perineuronal glial response after axotomy of central and peripheral axons: a comparison. Brain Res 1990;523:219-229.
45. Giulian D, Baker TJ, Shih L-CN, Lachman LB. Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986;164:594-604.
46. Giulian D, Chen J, Ingeman JE, George JK, Noponen M. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 1989;9: 4416-4429.
47. Giulian D, Lachman LB. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 1985;228:497-499.
48. Hetier E, Ayala J, Denefle P, et al. Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitro. J Neurosci Res 1988;21:391-397.
49. Nagy D, Kato T, Kushner PD. Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis. J Neurosci Res 1994;38:336-347.
50. Piani D, Frei K, Do KQ, Cuenod M, Fontana A. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett 1991;133:159-162.
51. Mattson MP, Zhang Y, Bose S. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp Neurol 1993;121:1-13.
52. Cheng B, Mattson MP. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 1991;7:1031-1041.
53. Mattson MP, Cheng B. Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis. Stroke 1993;24:I136-I140.
54. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem 1992;59:99-106.
55. Jackson GR, Apffel K, Werrbach-Perez K, Perez-Polo JR. Role of nerve growth factor in oxidant-antioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance. J Neurosci Res 1990;25:360-368.
56. Pan Z, Perez-Polo R. Role of nerve growth factor in oxidant homeostasis: glutathione metabolism. J Neurochem 1993;6: 1713-1720.
57. Sampath D, Jackson GR, Werrbach-Perez K, Perez-Polo JR. Effects of nerve growth factor on glutathione peroxidase and catalase in PC12 cells. J Neurochem 1994;62:2476-2479.
58. Zhang Y, Tatsuno T, Carney JM, Mattson MP. Basic FGF, NGF, and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J Cereb Blood Flow Metab 1993;13:378-388.
59. Lindholm D. Role of neurotrophins in preventing glutamate induced neuronal cell death. J Neurol 1994;242:S16-S18.
60. Lindvall O, Kokaia Z, Bengzon J, Elmer E, Kokaia M. Neurotrophins and brain insults. Trends Neurosci 1994;17:490-494.
61. Mitsumoto H, Ikeda K, Holmlund T, et al. The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol 1994;36:142-148.
62. Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum JM, Wong V, Lindsay RM. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 1994;265:1107-1110.
63. Sendtner M, Dittrich F, Hughes RA, Thoenen H. Actions of CNTF and neurotrophins on degenerating motoneurons: pre-clinical studies and clinical implications. J Neurol Sci 1994; 124:77-83.